Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME)

Study Identifier
GMA-EAME-EYE-0440
CT.gov Identifier
NCT03003416
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Macular Edema
    • Study Drug
  • dexamethasone intravitreal implant
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    -Patient with Diabetic Macular Edema (DME) treated with Ozurdex® in clinical practice.
    Exclusion Criteria:
    -Patient not residing in metropolitan France.

    Protocol Summary

    This study will evaluate the efficacy of Ozurdex® as prescribed in clinical practice in France for the treatment of Diabetic Macular Edema (DME).

    Study Locations

    Location
    Status
    Location
    Centre MGM
    Aix-en-Provence, France, 13090
    Status
    Not applicable
    Location
    Ballanger
    Aulnay-sous-Bois, France, 93600
    Status
    Not applicable
    Location
    CH BLOIS
    Blois, France, 41016
    Status
    Not applicable
    Location
    CH Avicennes Bobigny
    Bobigny, France, 93000
    Status
    Not applicable
    Location
    Centre Rétine Gallien à Bordeaux
    Bordeaux, France, 33000
    Status
    Not applicable
    Location
    CHU Bordeaux
    Bordeaux, France, 33000
    Status
    Not applicable
    Showing {first} - {last} of {total} Results